Results 91 to 100 of about 5,604 (216)

Osmolytes as mediators of the muscle tissue’s responses to inflammation : emerging regulators of myositis with therapeutic potential [PDF]

open access: yes, 2017
Chronic inflammation of skeletal muscle tissues termed myositis is associated with inherited muscular dystrophy and with acquired inflammatory myopathy.
De Paepe, Boel
core   +1 more source

Treatment and outcomes in necrotising autoimmune myopathy: an australian perspective [PDF]

open access: yes, 2016
Necrotising Autoimmune Myopathy (NAM) presents as a subacute proximal myopathy with high creatine kinase levels. It is associated with statin exposure, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) antibody, connective tissue diseases, signal ...
Ashton, C.   +4 more
core   +1 more source

Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies [PDF]

open access: hybrid, 2022
Laura Fionda   +16 more
openalex   +1 more source

Immune-mediated Necrotizing Myopathy in a Patient with Microscopic Polyangiitis

open access: yesInternal Medicine
We herein report a case of immune-mediated necrotizing myopathy (IMNM) in a patient with microscopic polyangiitis (MPA). A 77-year-old Japanese woman presented with a 2-day history of proximal muscle weakness and myalgia, with elevated serum creatinine kinase (CK) levels.
Umemoto, Daichi   +8 more
openaire   +2 more sources

Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy [PDF]

open access: yes
Introduction Statin use can lead to various muscle-related issues, including benign creatine kinase (CK) elevations, myalgias, toxic myopathies, rhabdomyolysis, and immune-mediated necrotizing myositis (IMNM), which primarily affects ...
Atiya, Monika   +5 more
core   +1 more source

Histopathology of the muscle in rheumatic diseases. [PDF]

open access: yes, 2018
The presence of muscular symptoms is common in rheumatological clinical practice, but often the differential diagnosis between muscular involvement in connective tissue diseases, vasculitis and drug-induced myopathy may be difficult.
A. Tripoli   +4 more
core   +2 more sources

A novel therapeutic strategy for pancreatic neoplasia using a novel RNAi platform targeting PDX-1 [PDF]

open access: yes, 2011
Bi-functional shRNA (bi-shRNA), a novel RNA interference (RNAi) effector platform targeting PDX-1 utilizing a systemic DOTAP-Cholesterol delivery vehicle, was studied in three mouse models of progressive pancreatic neoplasia.
Charles Brunicardi   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy